BRIDGE-DS study: a multicenter, observational, retrospective analysis of dapagliflozin and sitagliptin combination on modifiable cardiovascular risk factors in T2DM patients with ASCVD or high cardiovascular risk
BRIDGE-DS 研究：一项多中心、观察性、回顾性分析，旨在评估达格列净联合西格列汀治疗对合并动脉粥样硬化性心血管疾病或高心血管风险的 2 型糖尿病患者可改变的心血管危险因素的影响。
期刊:Cardiovascular Endocrinology & Metabolism
影响因子:1.1
doi:10.1097/XCE.0000000000000330
Bhamri, Naveen; Kumar, Ashutosh; Mishra, Chandrakant; Devarbhavi, Praveen Kumar; Prasad, Surendra; Rudach, Devanand Samatbhai; Potdar, Anil; Patil, Sachin Narendra; Tewari, Ajoy Kumar; Jagdish, P S; Gayan, Rajib; Bansal, Sunil; Maheshbabu, Chinnakonda R; Asalkar, Amit H; Chitale, Manoj; Kesarkar, Rohan Narayan; Prasad, Ashish; Pednekar, Abhijit
